Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04705922 · ClinicalTrials.gov registry record · Phase 1
Relative Bioavailability Study and Food Effect Study of TT-00420 (Tinengotinib) Capsule and Tablet Formulations in Healthy Volunteers
A Phase 1 study, sponsored by TransThera Sciences (Nanjing).
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT04705922 is a Phase 1 study that has completed, run by TransThera Sciences (Nanjing). The registered enrollment target is 24 participants.
The verdict
NCT04705922, a Phase 1 study, has completed, sponsored by TransThera Sciences (Nanjing).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study is an open-label, 3-way crossover randomized study in adult healthy volunteers to evaluate the relative bioavailability of TT-00420 tablet and capsule formulations and to evaluate food effect on the pharmacokinetics of TT-00420 tablet.
Interventions
- DRUG TT-00420 Capsule
- DRUG TT-00420 Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2020-12-29 |
| Est. Completion | 2021-07-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04705922
The ClinicalTrials.gov registry entry for NCT04705922 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TransThera Sciences (Nanjing), which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TT-00420 Capsule is the first listed.
NCT04705922 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04705922 about?
NCT04705922 is a clinical study titled "Relative Bioavailability Study and Food Effect Study of TT-00420 (Tinengotinib) Capsule and Tablet Formulations in Healthy Volunteers". This study is an open-label, 3-way crossover randomized study in adult healthy volunteers to evaluate the relative bioavailability of TT-00420 tablet and capsule formulations and to evaluate food effect on the pharmacokinetics of TT-00420 tablet.
What is the current status of trial NCT04705922?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2020-12-29. Estimated completion is 2021-07-23.
What interventions are being tested in trial NCT04705922?
The interventions under investigation include: TT-00420 Capsule (DRUG), TT-00420 Tablet (DRUG).
Who is sponsoring clinical trial NCT04705922?
This trial is sponsored by TransThera Sciences (Nanjing), which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.